Infusion Laboratory: Protocol 3 (Risperidone) - 4

NCT00000339 · clinicaltrials.gov ↗

PHASE1

Phase

UNKNOWN

Status

13

Enrollment

NIH

Sponsor class

Conditions

Cocaine-Related Disorders

Interventions

DRUG: Risperidone

Sponsor

National Institute on Drug Abuse (NIDA)